PE20070010A1 - Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactasas clase d - Google Patents

Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactasas clase d

Info

Publication number
PE20070010A1
PE20070010A1 PE2006000563A PE2006000563A PE20070010A1 PE 20070010 A1 PE20070010 A1 PE 20070010A1 PE 2006000563 A PE2006000563 A PE 2006000563A PE 2006000563 A PE2006000563 A PE 2006000563A PE 20070010 A1 PE20070010 A1 PE 20070010A1
Authority
PE
Peru
Prior art keywords
eno
oxo
carboxyl
class
penems
Prior art date
Application number
PE2006000563A
Other languages
English (en)
Spanish (es)
Inventor
Tarek Suhayl Mansour
Aranapakam Mudumbai Venkatesan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20070010A1 publication Critical patent/PE20070010A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PE2006000563A 2005-06-01 2006-05-31 Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactasas clase d PE20070010A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68622105P 2005-06-01 2005-06-01

Publications (1)

Publication Number Publication Date
PE20070010A1 true PE20070010A1 (es) 2007-01-12

Family

ID=37836305

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000563A PE20070010A1 (es) 2005-06-01 2006-05-31 Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactasas clase d

Country Status (14)

Country Link
US (1) US20060276446A1 (enExample)
EP (1) EP1885358A2 (enExample)
JP (1) JP2008542376A (enExample)
CN (1) CN101189010A (enExample)
AR (1) AR054467A1 (enExample)
AU (1) AU2006287938A1 (enExample)
BR (1) BRPI0611491A2 (enExample)
CA (1) CA2610478A1 (enExample)
GT (1) GT200600235A (enExample)
MX (1) MX2007015173A (enExample)
PE (1) PE20070010A1 (enExample)
SV (1) SV2007002555A (enExample)
TW (1) TW200716104A (enExample)
WO (1) WO2007030166A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
US8512789B2 (en) * 2005-11-23 2013-08-20 The Coca-Cola Company High-potency sweetener composition with dietary fiber and compositions sweetened therewith
US8524304B2 (en) 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
US8945652B2 (en) 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
JP2012121809A (ja) * 2009-02-26 2012-06-28 Eisai R & D Management Co Ltd 多環式化合物の製造法およびその中間体
US20110288063A1 (en) * 2010-05-19 2011-11-24 Naeja Pharmaceutical Inc. Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
CN104341345B (zh) * 2014-10-24 2016-03-23 海门海康生物医药科技有限公司 一种2-甲氧基-6-酮-5,6,7,8-四氢喹啉的合成方法
EP3936192B1 (en) 2019-03-06 2025-04-09 Daiichi Sankyo Company, Limited Pyrrolopyrazole derivative

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ285085A (en) * 1994-04-25 1998-04-27 Smithkline Beecham Plc Penem composition, pharmaceutical formulation containing a beta-lactamase inhibiting penem and a beta-lactam antibiotic
US20040132706A1 (en) * 2001-10-05 2004-07-08 Daniela Salvemini Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension
AR039476A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp Proceso para preparar derivados de 6-alquiliden penem
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors

Also Published As

Publication number Publication date
JP2008542376A (ja) 2008-11-27
BRPI0611491A2 (pt) 2010-12-21
WO2007030166A3 (en) 2007-05-24
WO2007030166A2 (en) 2007-03-15
CN101189010A (zh) 2008-05-28
AU2006287938A1 (en) 2007-03-15
GT200600235A (es) 2007-03-29
TW200716104A (en) 2007-05-01
CA2610478A1 (en) 2007-03-15
EP1885358A2 (en) 2008-02-13
SV2007002555A (es) 2007-02-02
AR054467A1 (es) 2007-06-27
US20060276446A1 (en) 2006-12-07
MX2007015173A (es) 2008-02-15

Similar Documents

Publication Publication Date Title
PE20171341A1 (es) Compuestos de pirazina para el tratamiento de enfermedades infecciosas
PE20110122A1 (es) COMPUESTOS DERIVADOS DE 9H-PIRROLO[2,3-b:5,4-c]DIPIRIDIN-6-(PIRIDIN-3-IL) COMO INHIBIDORES DE LAS CINASA Pim
PE20090511A1 (es) Imidazopiridinonas
PE20130346A1 (es) Compuestos heterociclicos fusionados
PE20091833A1 (es) Derivados heterociclicos espiro biciclicos o heterociclicos biciclicos, puenteados, de pirazolo [1,5-a]pirimidinas como inhibidores de quinasas raf y metodos para su preparacion
PE20120505A1 (es) Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona como moduladores de pde9a
PE20110387A1 (es) Aminotriazolo-piridinas como inhibidores de cinasa
PE20071104A1 (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv (dpp-4)
PE20090370A1 (es) Derivados de heterociclo fusionado como inhibidores de quinasa
EA201170771A1 (ru) Органические соединения
PE20070367A1 (es) Compuestos de espiropiperidina como inhibidores de la enzima beta secretasa
PE20080931A1 (es) Imidazopirazinas como inhibidores de proteina quinasa
PE20110545A1 (es) Compuestos de triazolopiridina como inhibidores de jak
PE20091211A1 (es) Derivados de pirazolopirimidina como moduladores de pde9a
PE20110296A1 (es) Compuestos heterociclicos fusionados como moduladores del receptor de orexina
PE20090648A1 (es) Compuestos para el tratamiento de la hepatitis c
PE20091414A1 (es) FURO [3,2-c] PIRIDINA Y TIENO [3,2-c] PIRIDINAS
PE20061484A1 (es) Compuestos triciclicos fusionados como inhibidores de la actividad de quinesina de ksp
PE20140970A1 (es) Derivados de 6-ciclobutil-1,5-dihidro-pirazol [3,4-d) pirimidin-4-ona y su uso como inhibidores de pde9a
PE20121438A1 (es) Derivados de imidazopiridina o imidazopirimidina como inhibidores de fosfodiesterasa 10a
PE20070010A1 (es) Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactasas clase d
PE20110560A1 (es) NUEVOS DERIVADOS DE TRIAZOLO[4,3-a]PIRIDINA, SU PROCEDIMIENTO DE PREPARACION, SU APLICACION COMO MEDICAMENTOS, COMPOSICIONES FARMACEUTICAS Y NUEVA UTILIZACION PARTICULARMENTE COMO INHIBIDORES DE MET
JO3611B1 (ar) سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
PE20080145A1 (es) Tetrahidro-pirimidoazepinas como moduladores de trpv1
PE20130640A1 (es) Compuestos heterociclicos, su preparacion y su aplicacion terapeutica

Legal Events

Date Code Title Description
FC Refusal